rs1341863
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001103.4(ACTN2):c.378C>T(p.Asn126Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.98 in 1,611,842 control chromosomes in the GnomAD database, including 776,125 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.93 ( 66858 hom., cov: 33)
Exomes 𝑓: 0.99 ( 709267 hom. )
Consequence
ACTN2
NM_001103.4 synonymous
NM_001103.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.102
Publications
22 publications found
Genes affected
ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ACTN2 Gene-Disease associations (from GenCC):
- intrinsic cardiomyopathyInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Laboratory for Molecular Medicine, ClinGen
- myopathy, congenital, with structured cores and z-line abnormalitiesInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathy 1AAInheritance: AD Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- myopathy, distal, 6, adult-onset, autosomal dominantInheritance: AD, Unknown Classification: LIMITED Submitted by: Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 1-236720121-C-T is Benign according to our data. Variant chr1-236720121-C-T is described in ClinVar as [Benign]. Clinvar id is 43938.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.102 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.989 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.378C>T | p.Asn126Asn | synonymous_variant | Exon 4 of 21 | ENST00000366578.6 | NP_001094.1 | |
ACTN2 | NM_001278343.2 | c.378C>T | p.Asn126Asn | synonymous_variant | Exon 4 of 21 | NP_001265272.1 | ||
ACTN2 | NR_184402.1 | n.553C>T | non_coding_transcript_exon_variant | Exon 4 of 23 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.934 AC: 142084AN: 152138Hom.: 66832 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
142084
AN:
152138
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.961 AC: 241683AN: 251374 AF XY: 0.968 show subpopulations
GnomAD2 exomes
AF:
AC:
241683
AN:
251374
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.985 AC: 1437881AN: 1459586Hom.: 709267 Cov.: 35 AF XY: 0.986 AC XY: 715849AN XY: 726288 show subpopulations
GnomAD4 exome
AF:
AC:
1437881
AN:
1459586
Hom.:
Cov.:
35
AF XY:
AC XY:
715849
AN XY:
726288
show subpopulations
African (AFR)
AF:
AC:
27022
AN:
33426
American (AMR)
AF:
AC:
39014
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
26116
AN:
26124
East Asian (EAS)
AF:
AC:
39030
AN:
39670
South Asian (SAS)
AF:
AC:
83728
AN:
86200
European-Finnish (FIN)
AF:
AC:
52835
AN:
53416
Middle Eastern (MID)
AF:
AC:
5675
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
1105522
AN:
1109962
Other (OTH)
AF:
AC:
58939
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
1051
2102
3152
4203
5254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.934 AC: 142161AN: 152256Hom.: 66858 Cov.: 33 AF XY: 0.933 AC XY: 69421AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
142161
AN:
152256
Hom.:
Cov.:
33
AF XY:
AC XY:
69421
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
33752
AN:
41488
American (AMR)
AF:
AC:
13708
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
3472
AN:
3472
East Asian (EAS)
AF:
AC:
5105
AN:
5184
South Asian (SAS)
AF:
AC:
4688
AN:
4834
European-Finnish (FIN)
AF:
AC:
10478
AN:
10618
Middle Eastern (MID)
AF:
AC:
286
AN:
294
European-Non Finnish (NFE)
AF:
AC:
67754
AN:
68048
Other (OTH)
AF:
AC:
2006
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
420
839
1259
1678
2098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3351
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Jul 20, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Myopathy, congenital, with structured cores and z-line abnormalities Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cardiovascular phenotype Benign:1
Mar 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.